Rubedo is making new engineered "smart" small molecules for targeted senolytic customized therapies. We have two preclinical programs in lead optimization stage, one for respiratory and lung diseases and one for oncology.
The team includes world leader Pharma drug hunters (such as from Merck, Novartis, Verily Google Life Sciences, Genentech) and top IT lead engineers (such as from Facebook).